Changes in Glycemic Outcomes Following FreeStyle Libre Initiation Among Individuals with Type 1 Diabetes, Insulin-Intensive Type 2 Diabetes, and Basal Insulin-Treated Type 2 Diabetes: A Retrospective Pre–Post Study in Saudi Arabia
Background/Objectives: Data describing glycemic changes after FreeStyle Libre (FSL) initiation in insulin-treated patients in Saudi Arabia are limited. We compared period-average HbA1c and hospital-recorded acute diabetes events (ADEs) during the 12 months before and after FSL initiation. Methods: This single-center retrospective uncontrolled pre–post cohort included 202 individuals first prescribed FSL between February and July 2023 who had at least three post-initiation sensor dispensing/refill records and no documented discontinuation. The refill criterion selects participants based on follow-up behavior. HbA1c was averaged within each 12-month period. Results: Among 202 participants (70 T1DM, 67 T2DM-MDI, 65 T2DM-Basal), mean HbA1c was 9.1 ± 1.9% before and 8.7 ± 1.8% after initiation (mean within-person change −0.44 percentage points, 95% CI −0.67 to −0.21; paired t-test p < 0.001). Within-group changes were −0.19 (p = 0.318), −0.58 (p = 0.009), and −0.55 (p = 0.008) percentage points in T1DM, T2DM-MDI, and T2DM-Basal, respectively. Between-group differences in change were not significant (ANOVA p = 0.316; Kruskal–Wallis p = 0.137); the common-slope ANCOVA group effect was nonsignificant (F[2, 198] = 1.58, p = 0.208), but the group × baseline HbA1c interaction was significant (F[2, 196] = 4.27, p = 0.015). Exploratory conditional pairwise contrasts at baseline HbA1c levels of 8%, 9% and 10% were not significant after multiplicity adjustment. Exploratory baseline-HbA1c strata were not multiplicity-adjusted and are vulnerable to regression to the mean. ADE counts were sparse. Conclusions: Lower mean HbA1c was observed after FSL initiation among selected patients, particularly in the two T2DM groups within-group; an independent FSL effect cannot be inferred without a comparator or treatment-change information.
Authors
- Raed Aldahash (ORCID: https://orcid.org/0000-0001-9612-4072)
- Ahmed R Alibrahim (ORCID: https://orcid.org/0000-0001-5389-9433)
- Saeed Mastour Alshahrani (ORCID: https://orcid.org/0000-0003-2714-7785)
- Meshari Al Samih (ORCID: https://orcid.org/0009-0009-0113-0580)
- Mohammed Alkhalaf (ORCID: https://orcid.org/0009-0001-4328-5080)
- Nawaf Alagrafy (ORCID: https://orcid.org/0009-0004-2018-1539)
- Yazeed Alqahtani
Institutions
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdulaziz Medical City (SA)
- National Guard Health Affairs (SA)
- King Khalid University (SA)
Publication Details
- Journal
- Healthcare
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/healthcare14223931
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Abbott Diabetes Care